Skip to content

Comparison of intragastric vs intrajejunal feeding in chronic pancreatitis; effect on abdominal symptoms

Comparison of intragastric vs intrajejunal feeding in chronic pancreatitis; effect on abdominal symptoms - Enteral nutrition and pain in pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29917
Enrollment
20
Registered
2006-09-15
Start date
2006-08-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pancreatitis

Interventions

Intragastric and intrajejunal tube feeding.

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: · Pain is aggravated by meal ingestion, at least 3 times per week in past month · Pain most likely due to chronic pancreatitis (CP) · Pain is daily (type B-pain) · Pain is stable for more than 3 months · Clinical indication for enteral feeding · Diagnosis of chronic pancreatitis · Age > 18 y;

Exclusion criteria

Exclusion criteria: · Intermittent pain with pain free days (type A pain) · Exocrine pancreatic insufficiency · Duodenal or choledochal stenosis · Narcotic analgesics except tramadol · Surgery of stomach, pancreas, duodenum or jejunum · Jejunostomy for enteral feeding · Instable pain medication · No abstinence from alcohol in alcoholic CP · Evidence that abdominal pain may not be related to feeding or may not originate from pancreas · Other disorders of the upper gastrointestinal tract · Liver or biliary disorders . Contra-indication for enteral tube placement . Pregnancy

Design outcomes

Primary

MeasureTime frame
Intensity of abdominal pain

Secondary

MeasureTime frame
Secondary parameters of the study are severity of other abdominal symptoms, health related quality of life, global releave score, global evaluation of efficacy score, concentrations of circulating gut hormones.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)